Targeting Neovascularization in Graft-Versus-Host Disease |
Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD |
Innovation Grants |
2012 |
New York |
The role of NOTCH1 in T-cell acute lymphoblastic leukemia. |
Columbia University Medical Center / Adolfo Ferrando |
Bridge Grants |
2012 |
New York |
Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research |
Washington University / Kimberly Johnson Ph.D. |
Epidemiology Grants |
2012 |
Missouri |
Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia |
Washington University / Grant Challen, PhD |
'A' Award Grants |
2012 |
Missouri |
Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL |
The Johns Hopkins University School of Medicine / Donald Small, MD, PhD |
Innovation Grants |
2012 |
Maryland |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening |
Dana-Farber Cancer Institute / Stuart Orkin, MD |
Innovation Grants |
2012 |
Massachusetts |
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma |
Dana-Farber Cancer Institute / Kimberly Stegmaier, MD |
Bridge Grants |
2012 |
Massachusetts |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |